New Zealand markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1100-0.0700 (-3.21%)
At close: 4:00PM EDT
2.1000 -0.01 (-0.47%)
After hours: 07:41PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5196.37M
Enterprise value 3181.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)12.80
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-30.81

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-84.37%
S&P500 52-week change 333.64%
52-week high 333.5500
52-week low 32.0400
50-day moving average 32.5682
200-day moving average 34.5091

Share statistics

Avg vol (3-month) 32.28M
Avg vol (10-day) 3950.94k
Shares outstanding 586.89M
Implied shares outstanding 6N/A
Float 850.18M
% held by insiders 148.64%
% held by institutions 16.32%
Shares short (29 Sep 2021) 4279.08k
Short ratio (29 Sep 2021) 40.07
Short % of float (29 Sep 2021) 40.49%
Short % of shares outstanding (29 Sep 2021) 40.32%
Shares short (prior month 30 Aug 2021) 4520.7k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Apr 2021
Most-recent quarter (mrq)30 Jul 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)-74.85%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-6.05M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.62M
Total cash per share (mrq)0.18
Total debt (mrq)400.85k
Total debt/equity (mrq)2.61
Current ratio (mrq)11.41
Book value per share (mrq)0.18

Cash flow statement

Operating cash flow (ttm)-3.73M
Levered free cash flow (ttm)N/A